Ma Tiantian – HKU COVID-19 Digital Archives

Ma Tiantian

DEPT

Department of Pharmacology and Pharmacy

FACULTY

Li Ka Shing Faculty of Medicine

COVID-19 Contribution

Showing 1 - 7 out of 7

Show

Relevance

01 Mar 2023
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
L
Li, X
P
Peng, K
C
Cheng, FWT
L
Lam, CLD
C
Cheung, CL
C
Chui, SLC
L
Lai, TTF
W
Wan, YFE
W
Wong, CKH
M
Ma, T
Y
Yum, SHH
C
Chan, EWY
H
Huang, J
L
Lau, WCS
I
Ip, MSM
W
Wong, ICK
Coronavirus vaccines Innate immunity Tuberculosis
31 Dec 2022
Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study
Data regarding protection against mortality and severe complications after Omicron BA.2 infection with CoronaVac and BNT162b2 vaccines remains limited...Read more
Y
Yan, KCV
W
Wan, YFE
Y
Ye, X
M
Mok, AHY
L
Lai, TTF
C
Chui, SLC
L
Li, X
W
Wong, CKH
L
Li, PH
M
Ma, T
Q
Qin, S
C
Cowling, BJ
L
Leung, GM
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
01 Dec 2022
Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong
Prior research using electronic health records for Covid-19 vaccine safety monitoring typically focuses on specific disease groups and excludes indivi...Read more
L
Lai, TTF
H
Huang, L
C
Chui, SLC
W
Wan, YFE
L
Li, X
W
Wong, CKH
C
Chan, EWW
M
Ma, T
L
Luo, H
C
Chan, EWY
W
Wong, ICK
03 May 2023
Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study
BACKGROUND: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where da...Read more
Y
Yan, KCV
W
Wan, YFE
Y
Ye, X
M
Mok, AHY
L
Lai, TTF
C
Chui, SLC
L
Li, X
W
Wong, CKH
L
Li, PH
M
Ma, T
Q
Qin, S
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
drug development Epidemiology General Medicine immunology Infectious disease Microbiology Parasitology virology
20 Feb 2023
Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study
Background: Multimorbidity is a prevalent risk factor for COVID-19–related complications and death. We sought to evaluate the association of homologou...Read more
L
Lai, TTF
Y
Yan, KCV
Y
Ye, X
M
Ma, T
Q
Qin, X
C
Chui, SLC
L
Li, X
W
Wan, YFE
W
Wong, CKH
C
Cheung, CL
L
Li, PH
C
Cheung, BMY
L
Lau, WCS
W
Wong, ICK
C
Chan, EWY
27 Jul 2022
Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease
Aims: Concern about the cardiovascular safety of coronavirus disease 2019 (COVID-19) vaccines among individuals with cardiovascular disease (CVD) may ...Read more
Y
Ye, X
M
Ma, T
B
Blais, JE
Y
Yan, KCV
K
Kang, WF
C
Chui, SLC
L
Lai, TTF
L
Li, X
W
Wan, YFE
W
Wong, CKH
T
Tse, HF
S
Siu, DCW
W
Wong, ICK
C
Chan, EWY
31 Dec 2022
Adverse Events of Special Interest Following the Use of BNT162b2 in Adolescents: A Population-Based Retrospective Cohort Study
Accruing evidence suggests an increased risk of myocarditis in adolescents from messenger RNA COVID-19 vaccines. However, other potential adverse even...Read more
L
Lai, TTF
C
Chua, GT
C
Chan, EWW
H
Huang, L
M
Ma, T
Q
Qin, X
C
Chui, SLC
L
Li, X
W
Wan, YFE
W
Wong, CKH
C
Chan, EWY
W
Wong, ICK
I
Ip, P

01 Mar 2023

Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)

31 Dec 2022

Effectiveness of BNT162b2 and CoronaVac vaccinations against mortality and severe complications after SARS-CoV-2 Omicron BA.2 infection: a case–control study

01 Dec 2022

Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong

03 May 2023

Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study

20 Feb 2023

Booster vaccination with inactivated whole-virus or mRNA vaccines and COVID-19–related deaths among people with multimorbidity: a cohort study

27 Jul 2022

Association between BNT162b2 or CoronaVac COVID-19 vaccines and major adverse cardiovascular events among individuals with cardiovascular disease

31 Dec 2022

Adverse Events of Special Interest Following the Use of BNT162b2 in Adolescents: A Population-Based Retrospective Cohort Study

Site Map

About

Policy

Copyright © 2023 - University Libraries, The University of Hong Kong